TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Telomir Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.04−0.01 (-0.95%)
Close on Oct 19, 2026
- Market cap
- $63.27M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
4.3%
3M of 69M shares
Institutional holders
33
11 new, 5 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity | 3,554,871 | 5.17% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TELO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,613,639 | 2.35% | $2.07M | +618,266 | 0.00% |
| Geode Capital Management, LLC | 338,875 | 0.49% | $433.91K | +89,789 | 0.00% |
| BlackRock, Inc. | 280,472 | 0.41% | $359.00K | −8,726 | 0.00% |
| Vanguard Fiduciary Trust Co | 225,304 | 0.33% | $288.39K | +89,763 | 0.00% |
| Northern Trust Corp | 61,532 | 0.09% | $78.76K | +19,688 | 0.00% |
| State Street Corp | 58,600 | 0.09% | $75.01K | – | 0.00% |
| Bank of New York Mellon Corp | 51,454 | 0.07% | $65.86K | – | 0.00% |
| Captrust Financial Advisors | 51,194 | 0.07% | $65.53K | New | 0.00% |
| Osaic Holdings, Inc. | 41,490 | 0.06% | $53.11K | +5,695 | 0.00% |
| Pensionmark Financial Group, LLC | 37,037 | 0.05% | $48.15K | – | 0.00% |
| OneDigital Investment Advisors LLC | 23,000 | 0.03% | $29.44K | – | 0.00% |
| Qube Research & Technologies Ltd | 21,792 | 0.03% | $27.89K | New | 0.00% |
| Praetorian Wealth Management, Inc. | 20,000 | 0.03% | $25.60K | – | 0.00% |
| Virtu Financial LLC | 17,546 | 0.03% | $22 | New | 0.00% |
| Vestmark Advisory Solutions, Inc. | 13,600 | 0.02% | $17.41K | +500 | 0.00% |
| Citadel Advisors LLC | 13,266 | 0.02% | $16.98K | New | 0.00% |
| Morton Capital Management LLC/CA | 12,658 | 0.02% | $16.20K | – | 0.00% |
| Two Sigma Securities, LLC | 12,616 | 0.02% | $16.15K | New | 0.00% |
| Clearstead Advisors, LLC | 12,530 | 0.02% | $16.04K | – | 0.00% |
| NorthCrest Asset Manangement, LLC | 12,119 | 0.02% | $15.39K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 33 | 3M | 4.3% | 11 / 6 | 3 / 5 | 1M | 0M |
| Q1 2026 | 27 | 2M | 3.3% | 5 / 5 | 3 / 10 | 1M | 0M |
| Q4 2025 | 33 | 2M | 3.3% | 9 / 3 | 8 / 8 | 0M | 0M |
| Q3 2025 | 32 | 2M | 3.4% | 6 / 6 | 16 / 17 | 0M | 1M |
| Q2 2025 | 43 | 3M | 4.1% | 17 / 10 | 15 / 16 | 1M | 2M |
| Q1 2025 | 42 | 4M | 5.4% | 8 / 13 | 14 / 4 | 0M | 0M |
| Q4 2024 | 39 | 4M | 5.2% | 8 / 26 | 0 / 3 | 2M | 0M |
| Q3 2024 | 34 | 2M | 3.0% | 10 / 14 | 5 / 0 | 2M | 0M |
| Q2 2024 | 25 | 0M | 0.5% | 20 / 2 | 2 / 2 | 0M | 0M |
| Q1 2024 | 7 | 0M | 0.1% | 7 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TELO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,121,175 | 1.63% | $1.44M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 472,623 | 0.69% | $604.96K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 121,455 | 0.18% | $157.89K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 37,172 | 0.05% | $47.58K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 30,099 | 0.04% | $39.13K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 28,520 | 0.04% | $37.08K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 19,841 | 0.03% | $25.40K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 18,464 | 0.03% | $24.00K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 2,473 | 0.00% | $3.17K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Erez Aminov | CEO and Chairman, Director | 7,319,710 | 10.64% | May 22, 2026 |
| Andriy Mushak | Chief Financial Officer | – | – | Jun 9, 2026 |
| Alan Weichselbaum | Chief Financial Officer | – | – | Jun 10, 2025 |
| Giudice Matthew Paul Del | Director | – | – | Jul 27, 2026 |
| Matthew Pratt Whalen | Director | – | – | Jul 27, 2026 |
| Edward Clouston MacPherson | Director | – | – | Jul 27, 2026 |
| Mira Pharmaceuticals, Inc. | 10% owner | 3,521,127 | 5.12% | Oct 3, 2025 |
| Shore Trust Bay | 10% owner | 8,610,127 | 12.52% | Nov 25, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Erez Aminov CEO and Chairman, Director | Apr 22, 2026 | Other | +7,319,710 | $1.37 | $10.03M | 7,319,710 |
| Erez Aminov CEO and Chairman, Director | Aug 19, 2024 | Sale | −200 | $6.20 | $1.24K | 29,600 |
| Erez Aminov CEO and Chairman, Director | Aug 19, 2024 | Sale | −200 | $6.01 | $1.20K | 29,600 |
| Brian Patrick McNulty 10% owner | Feb 13, 2024 | Buy | +49,000 | $7.00 | $343.00K | 1,902,659 |
| Brian Patrick McNulty 10% owner | Feb 13, 2024 | Buy | +40,000 | $7.00 | $280.00K | 1,365,646 |
| Brian Patrick McNulty 10% owner | Feb 13, 2024 | Buy | +49,000 | $7.00 | $343.00K | 5,455,431 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.